RI H8172

Directs the Office of the Auditor General to conduct an independent study evaluating whether Rhode Island should consolidate prescription drug management for its Medicaid program, with a report due by March 31, 2027

Requires comparison of four prescription drug management models: Rhode Island's current multiple-PBM approach, single statewide preferred drug list, single state-contracted PBM, and state-administered fee-for-service

Mandates that pharmacy benefit managers, managed care organizations, rebate aggregators, and related entities provide complete, unredacted access to claims data, rebates, contracts, and pricing information upon request

Protects disclosed information as confidential commercial data while prohibiting confidentiality designations from being used to withhold information from auditors

Grants enforcement authority to the Office of the Auditor General and the Attorney General, with the act taking effect upon passage